510(k) K780335

LAS-R HUMAN C1 ESTERASE INHIBITOR TEST by Hyland Therapeutic Div., Travenol Laboratories — Product Code DBA

K780335 is an FDA 510(k) premarket notification submitted by Hyland Therapeutic Div., Travenol Laboratories for the device "LAS-R HUMAN C1 ESTERASE INHIBITOR TEST". The FDA issued a decision of Substantially Equivalent on Mar 22, 1978. The device falls under product code DBA (Complement C1 Inhibitor (Inactivator), Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5250. Hyland Therapeutic Div., Travenol Laboratories has 43 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Mar 22, 1978
Date Received
Feb 28, 1978
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Complement C1 Inhibitor (Inactivator), Antigen, Antiserum, Control
Device Class
Class II
Regulation Number
866.5250
Review Panel
IM
Submission Type
510(k)

Need the full FDA record for Hyland Therapeutic Div., Travenol Laboratories? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K780335. Report a data issue: hello@regdatalab.com.